205 related articles for article (PubMed ID: 27464728)
1. Solid Dispersions for Oral Administration: An Overview of the Methods for their Preparation.
Hallouard F; Mehenni L; Lahiani-Skiba M; Anouar Y; Skiba M
Curr Pharm Des; 2016; 22(32):4942-4958. PubMed ID: 27464728
[TBL] [Abstract][Full Text] [Related]
2. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
3. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
[TBL] [Abstract][Full Text] [Related]
4. Solid dispersions: revival with greater possibilities and applications in oral drug delivery.
Sethia S; Squillante E
Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):215-47. PubMed ID: 14584524
[TBL] [Abstract][Full Text] [Related]
5. Recent advances and patents in solid dispersion technology.
Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
[TBL] [Abstract][Full Text] [Related]
6. Delivery of poorly soluble compounds by amorphous solid dispersions.
Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
[TBL] [Abstract][Full Text] [Related]
7. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
[TBL] [Abstract][Full Text] [Related]
8. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
[TBL] [Abstract][Full Text] [Related]
9. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
Baghel S; Cathcart H; O'Reilly NJ
J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
[TBL] [Abstract][Full Text] [Related]
10. BCS class IV drugs: Highly notorious candidates for formulation development.
Ghadi R; Dand N
J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
[TBL] [Abstract][Full Text] [Related]
11. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
[TBL] [Abstract][Full Text] [Related]
12. Formation, Physicochemical Characterization, and Thermodynamic Stability of the Amorphous State of Drugs and Excipients.
Martino PD; Magnoni F; Peregrina DV; Gigliobianco MR; Censi R; Malaj L
Curr Pharm Des; 2016; 22(32):4959-4974. PubMed ID: 27464724
[TBL] [Abstract][Full Text] [Related]
13. Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study.
Sakurai A; Sakai T; Sako K; Maitani Y
Chem Pharm Bull (Tokyo); 2012; 60(4):459-64. PubMed ID: 22466729
[TBL] [Abstract][Full Text] [Related]
14. Physical chemical considerations of lipid-based oral drug delivery--solid lipid nanoparticles.
Bummer PM
Crit Rev Ther Drug Carrier Syst; 2004; 21(1):1-20. PubMed ID: 15099183
[TBL] [Abstract][Full Text] [Related]
15. Oral formulation strategies to improve solubility of poorly water-soluble drugs.
Singh A; Worku ZA; Van den Mooter G
Expert Opin Drug Deliv; 2011 Oct; 8(10):1361-78. PubMed ID: 21810062
[TBL] [Abstract][Full Text] [Related]
16. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
17. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
Vasconcelos T; Sarmento B; Costa P
Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the Literature and Patents on Solid Dispersions from 1980 to 2015.
Zhang J; Han R; Chen W; Zhang W; Li Y; Ji Y; Chen L; Pan H; Yang X; Pan W; Ouyang D
Molecules; 2018 Jul; 23(7):. PubMed ID: 30002275
[No Abstract] [Full Text] [Related]
19. Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.
Lin X; Hu Y; Liu L; Su L; Li N; Yu J; Tang B; Yang Z
Pharm Res; 2018 Apr; 35(6):125. PubMed ID: 29687226
[TBL] [Abstract][Full Text] [Related]
20. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
